Medications for Biliary Tract Neoplasms
4 results
Imfinzi (durvalumab)
(Durvalumab)AstraZeneca Pharmaceuticals LP
Usage: IMFINZI is indicated for treating various cancers in adults, including non-small cell lung cancer (both resectable and unresectable), small cell lung cancer (limited and extensive stage), biliary tract cancers, unresectable hepatocellular carcinoma, mismatch repair deficient endometrial cancer, and muscle invasive bladder cancer, often in combination with other therapies.
Indocyanine green (indocyanine green and water)
(Indocyanine Green and Water)Renew Pharmaceuticals Limited
Usage: Indocyanine Green is indicated for fluorescence imaging of vessels, blood flow, and tissue perfusion in various surgeries; visualization of extrahepatic biliary ducts; lymphatic mapping in cervical and uterine cancer; and ophthalmic angiography in adults and pediatric patients, ages 1 month and older.
Keytruda (pembrolizumab)
(pembrolizumab)Merck Sharp & Dohme LLC
Usage: KEYTRUDA® is indicated for treating various cancers, including melanoma, non-small cell lung cancer, malignant pleural mesothelioma, head and neck squamous cell cancer, classical Hodgkin lymphoma, and possible others, in both adults and children, depending on specific tumor characteristics and treatment history.
Ziihera (zanidatamab-hrii)
(zanidatamab-hrii)Jazz Pharmaceuticals, Inc.
Usage: ZIIHERA is indicated for treating adults with unresectable or metastatic HER2-positive biliary tract cancer (BTC) that has been previously treated, as determined by an FDA-approved test. This indication is based on accelerated approval due to overall response rate and duration of response.